Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA UNICHEM LAB ALEMBIC PHARMA/
UNICHEM LAB
 
P/E (TTM) x 41.7 -82.3 - View Chart
P/BV x 2.3 1.1 198.9% View Chart
Dividend Yield % 1.7 1.0 174.8%  

Financials

 ALEMBIC PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
UNICHEM LAB
Mar-22
ALEMBIC PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,090375 290.7%   
Low Rs672198 340.3%   
Sales per share (Unadj.) Rs269.9180.3 149.7%  
Earnings per share (Unadj.) Rs26.24.8 541.3%  
Cash flow per share (Unadj.) Rs40.817.8 229.4%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Avg Dividend yield %1.11.4 81.2%  
Book value per share (Unadj.) Rs266.5370.4 71.9%  
Shares outstanding (eoy) m196.5670.41 279.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.31.6 205.7%   
Avg P/E ratio x33.659.1 56.9%  
P/CF ratio (eoy) x21.616.1 134.2%  
Price / Book Value ratio x3.30.8 427.9%  
Dividend payout %38.182.5 46.2%   
Avg Mkt Cap Rs m173,17220,150 859.4%   
No. of employees `000NANA-   
Total wages/salary Rs m11,3303,305 342.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,05812,698 417.8%  
Other income Rs m505475 106.3%   
Total revenues Rs m53,56313,173 406.6%   
Gross profit Rs m8,741728 1,200.9%  
Depreciation Rs m2,868912 314.6%   
Interest Rs m17761 290.4%   
Profit before tax Rs m6,201230 2,692.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,045-111 -941.7%   
Profit after tax Rs m5,157341 1,511.2%  
Gross profit margin %16.55.7 287.4%  
Effective tax rate %16.8-48.2 -35.0%   
Net profit margin %9.72.7 361.7%  
BALANCE SHEET DATA
Current assets Rs m29,74816,484 180.5%   
Current liabilities Rs m18,3065,521 331.5%   
Net working cap to sales %21.686.3 25.0%  
Current ratio x1.63.0 54.4%  
Inventory Days Days11128 8.2%  
Debtors Days Days61,424 0.4%  
Net fixed assets Rs m42,55416,660 255.4%   
Share capital Rs m393141 279.2%   
"Free" reserves Rs m51,98225,937 200.4%   
Net worth Rs m52,37526,077 200.8%   
Long term debt Rs m0890 0.0%   
Total assets Rs m72,30233,144 218.1%  
Interest coverage x36.04.8 753.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.4 191.5%   
Return on assets %7.41.2 607.8%  
Return on equity %9.81.3 752.4%  
Return on capital %12.21.1 1,127.2%  
Exports to sales %43.869.2 63.3%   
Imports to sales %12.710.6 119.7%   
Exports (fob) Rs m23,2518,792 264.5%   
Imports (cif) Rs m6,7281,345 500.1%   
Fx inflow Rs m23,2518,792 264.5%   
Fx outflow Rs m6,7281,345 500.1%   
Net fx Rs m16,5237,447 221.9%   
CASH FLOW
From Operations Rs m5,524-2,596 -212.8%  
From Investments Rs m-3,7201,001 -371.5%  
From Financial Activity Rs m-2,1741,912 -113.7%  
Net Cashflow Rs m-370317 -116.5%  

Share Holding

Indian Promoters % 69.1 50.9 135.7%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.9 10.4 171.7%  
FIIs % 5.3 1.7 311.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 49.1 61.9%  
Shareholders   103,811 29,573 351.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Unichem Lab Share Price Performance

Period ALEMBIC PHARMA Unichem Lab S&P BSE HEALTHCARE
1-Day 0.49% -1.56% 0.23%
1-Month 9.17% 8.61% 0.36%
1-Year -25.08% 92.32% -6.87%
3-Year CAGR 1.98% 37.01% 20.16%
5-Year CAGR 3.24% 6.95% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Unichem Lab the stake stands at 50.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Unichem Lab paid Rs 4.0, and its dividend payout ratio stood at 82.5%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.